Phesi COVID-19 study indicates obesity a major complicating factor
The virtual clinical development firm’s analysis of patient profiles reflects obesity is the most significant indicator for severity in those under 40.
Archives for June 7, 2021
FDA approves Biogen’s Alzheimer's drug, Aduhelm
The US Food and Drug Administration (FDA) has approved Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer’s: making it the first new treatment approved for the disease since 2003.
Scaling up eConsent
Paid for and content provided by Signant Health
The informed consent process is fundamental to every clinical trial. Study participants must be provided with sufficient information to understand the study, its procedures and commitments, the possible treatments they may receive, and any possible...
Novo Nordisk weight-management drug lands FDA approval
The pharmacy company's Wegovy (semaglutide) is the first therapy designated for chronic weight management that the agency has granted approval since 2014.